• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痛风的诊治难点。

The Challenges of Approaching and Managing Gout.

机构信息

Division of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, Suite 848G, New York, NY 10021, USA.

出版信息

Rheum Dis Clin North Am. 2019 Feb;45(1):145-157. doi: 10.1016/j.rdc.2018.09.009.

DOI:10.1016/j.rdc.2018.09.009
PMID:30447743
Abstract

Despite many effective treatments for gout, its management remains a challenge internationally. Options for optimizing gout management may differ in different practice sizes and settings. Gout incidence is rising and it continues to be associated with increased mortality. Education of patients and medical providers is essential, and newer gout medications need to be used in the most appropriate ways for cost-effective therapy. Special consideration needs to be given to such populations as the elderly and those with renal and cardiovascular disease in gout management. New agents are in development, which may add to the armamentarium for gout management.

摘要

尽管有许多有效的痛风治疗方法,但国际上对其管理仍然是一个挑战。优化痛风管理的选择可能因实践规模和环境的不同而有所不同。痛风发病率不断上升,而且它仍然与死亡率增加有关。对患者和医疗服务提供者进行教育至关重要,需要以最有效的方式使用新型痛风药物进行成本效益治疗。在痛风管理中,需要特别考虑老年人以及患有肾脏和心血管疾病的人群。新的药物正在开发中,这可能会增加痛风管理的手段。

相似文献

1
The Challenges of Approaching and Managing Gout.痛风的诊治难点。
Rheum Dis Clin North Am. 2019 Feb;45(1):145-157. doi: 10.1016/j.rdc.2018.09.009.
2
Trends in Utilization of Urate-Lowering Therapies Following the US Food and Drug Administration's Boxed Warning on Febuxostat.美国食品药品监督管理局对非布司他发出黑框警告后降尿酸治疗的使用趋势
Arthritis Rheumatol. 2021 Mar;73(3):542-543. doi: 10.1002/art.41550. Epub 2021 Jan 27.
3
Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update.慢性高尿酸血症治疗策略:基于循证的更新。
Medicina (Kaunas). 2021 Jan 10;57(1):58. doi: 10.3390/medicina57010058.
4
Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic Model.非依从性和缓解对痛风治疗成本效益的影响:应用关联的药物计量学/药物经济学模型。
Value Health. 2018 Dec;21(12):1373-1381. doi: 10.1016/j.jval.2018.06.002. Epub 2018 Jul 26.
5
Achieving serum urate targets in gout: an audit in a gout-oriented rheumatology practice.在痛风患者中实现血清尿酸目标:一项针对痛风专科风湿病诊疗实践的审计
Int J Rheum Dis. 2017 Jul;20(7):894-897. doi: 10.1111/1756-185X.13032. Epub 2017 Feb 16.
6
Gout - An update of aetiology, genetics, co-morbidities and management.痛风——病因学、遗传学、共病及治疗的最新进展。
Maturitas. 2018 Dec;118:67-73. doi: 10.1016/j.maturitas.2018.10.012. Epub 2018 Oct 26.
7
Chronic Disease Approaches Needed to Curb Gout's Growing Burden.需要采用慢性病防治方法来遏制痛风日益加重的负担。
JAMA. 2018 Apr 3;319(13):1307-1309. doi: 10.1001/jama.2018.0547.
8
Update on emerging urate-lowering therapies.新型降尿酸疗法的最新进展。
Curr Opin Rheumatol. 2009 Mar;21(2):143-9. doi: 10.1097/BOR.0b013e328325bd94.
9
Adherence and persistence to urate-lowering therapies in the Irish setting.爱尔兰背景下对降尿酸治疗的依从性和持续性。
Clin Rheumatol. 2016 Mar;35(3):715-21. doi: 10.1007/s10067-014-2823-8. Epub 2014 Nov 20.
10
Emerging therapies for gout.痛风的新兴疗法。
Rheum Dis Clin North Am. 2014 May;40(2):375-87. doi: 10.1016/j.rdc.2014.01.013. Epub 2014 Feb 20.

引用本文的文献

1
Risk factors for loss to follow-up in patients with gout: A Korean prospective cohort study.痛风患者失访的危险因素:一项韩国前瞻性队列研究。
PLoS One. 2025 Feb 7;20(2):e0318564. doi: 10.1371/journal.pone.0318564. eCollection 2025.
2
Osteochondral organoids: current advances, applications, and upcoming challenges.软骨器官样体:当前的进展、应用和未来的挑战。
Stem Cell Res Ther. 2024 Jun 21;15(1):183. doi: 10.1186/s13287-024-03790-5.
3
RNA interference in the era of nucleic acid therapeutics.核酸治疗时代的RNA干扰
Nat Biotechnol. 2024 Mar;42(3):394-405. doi: 10.1038/s41587-023-02105-y. Epub 2024 Feb 26.
4
Stefin B alleviates the gouty arthritis in mice by inducing the M2 polarization of macrophages.Stefin B 通过诱导巨噬细胞 M2 极化来减轻小鼠痛风性关节炎。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5677-5688. doi: 10.1007/s00210-023-02911-w. Epub 2024 Jan 31.
5
Simple Application and Adherence to Gout Guidelines Enables Disease Control: An Observational Study in French Referral Centres.简单应用并遵循痛风指南可实现疾病控制:一项在法国转诊中心开展的观察性研究
J Clin Med. 2022 Sep 28;11(19):5742. doi: 10.3390/jcm11195742.
6
Revealing the pharmacological effect and mechanism of darutoside on gouty arthritis by liquid chromatography/mass spectrometry and metabolomics.通过液相色谱/质谱联用技术和代谢组学揭示达鲁糖苷对痛风性关节炎的药理作用及机制。
Front Mol Biosci. 2022 Aug 24;9:942303. doi: 10.3389/fmolb.2022.942303. eCollection 2022.
7
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout.开发并使用基于网络的个体化患者工具以支持痛风患者降尿酸治疗的依从性
BMC Med Inform Decis Mak. 2022 Apr 7;22(1):95. doi: 10.1186/s12911-022-01833-6.
8
Gouty Arthropathy: Review of Clinical Manifestations and Treatment, with Emphasis on Imaging.痛风性关节炎:临床表现与治疗综述,重点为影像学表现
J Clin Med. 2021 Dec 29;11(1):166. doi: 10.3390/jcm11010166.
9
A Traditional Clinic Chinese Medicine Prescription Qu-Zhuo-Tong-Bi () Alleviates Gouty Arthritis in Model Rats.一种传统中医临床处方祛浊通痹()缓解模型大鼠痛风性关节炎
Evid Based Complement Alternat Med. 2019 Dec 6;2019:9456318. doi: 10.1155/2019/9456318. eCollection 2019.